Mass spectrometry-based tear proteomics for noninvasive biomarker discovery
© 2021 The Authors. Mass Spectrometry Reviews published by John Wiley & Sons Ltd..
The lacrimal film has attracted increasing interest in the last decades as a potential source of biomarkers of physiopathological states, due to its accessibility, moderate complexity, and responsiveness to ocular and systemic diseases. High-performance liquid chromatography-mass spectrometry (LC-MS) has led to effective approaches to tear proteomics, despite the intrinsic limitations in sample amounts. This review focuses on the recent progress in strategy and technology, with an emphasis on the potential for personalized medicine. After an introduction on lacrimal-film composition, examples of applications to biomarker discovery are discussed, comparing approaches based on pooled-sample and single-tear analysis. Then, the most critical steps of the experimental pipeline, that is, tear collection, sample fractionation, and LC-MS implementation, are discussed with reference to proteome-coverage optimization. Advantages and challenges of the alternative procedures are highlighted. Despite the still limited number of studies, tear quantitative proteomics, including single-tear investigation, could offer unique contributions to the identification of low-invasiveness, sustained-accessibility biomarkers, and to the development of personalized approaches to therapy and diagnosis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
Mass spectrometry reviews - 41(2022), 5 vom: 24. Sept., Seite 842-860 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ponzini, Erika [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biomarkers |
|---|
| Anmerkungen: |
Date Completed 08.08.2022 Date Revised 15.10.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/mas.21691 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM323154522 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM323154522 | ||
| 003 | DE-627 | ||
| 005 | 20231225183552.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/mas.21691 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1077.xml |
| 035 | |a (DE-627)NLM323154522 | ||
| 035 | |a (NLM)33759206 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ponzini, Erika |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Mass spectrometry-based tear proteomics for noninvasive biomarker discovery |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.08.2022 | ||
| 500 | |a Date Revised 15.10.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021 The Authors. Mass Spectrometry Reviews published by John Wiley & Sons Ltd. | ||
| 520 | |a The lacrimal film has attracted increasing interest in the last decades as a potential source of biomarkers of physiopathological states, due to its accessibility, moderate complexity, and responsiveness to ocular and systemic diseases. High-performance liquid chromatography-mass spectrometry (LC-MS) has led to effective approaches to tear proteomics, despite the intrinsic limitations in sample amounts. This review focuses on the recent progress in strategy and technology, with an emphasis on the potential for personalized medicine. After an introduction on lacrimal-film composition, examples of applications to biomarker discovery are discussed, comparing approaches based on pooled-sample and single-tear analysis. Then, the most critical steps of the experimental pipeline, that is, tear collection, sample fractionation, and LC-MS implementation, are discussed with reference to proteome-coverage optimization. Advantages and challenges of the alternative procedures are highlighted. Despite the still limited number of studies, tear quantitative proteomics, including single-tear investigation, could offer unique contributions to the identification of low-invasiveness, sustained-accessibility biomarkers, and to the development of personalized approaches to therapy and diagnosis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a lacrimal film | |
| 650 | 4 | |a liquid biopsies | |
| 650 | 4 | |a peripheral body fluids | |
| 650 | 4 | |a personalized medicine | |
| 650 | 4 | |a single-tear analysis | |
| 650 | 4 | |a tear collection and fractionation methods | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 650 | 7 | |a Proteome |2 NLM | |
| 700 | 1 | |a Santambrogio, Carlo |e verfasserin |4 aut | |
| 700 | 1 | |a De Palma, Antonella |e verfasserin |4 aut | |
| 700 | 1 | |a Mauri, Pierluigi |e verfasserin |4 aut | |
| 700 | 1 | |a Tavazzi, Silvia |e verfasserin |4 aut | |
| 700 | 1 | |a Grandori, Rita |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Mass spectrometry reviews |d 1993 |g 41(2022), 5 vom: 24. Sept., Seite 842-860 |w (DE-627)NLM081945981 |x 1098-2787 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2022 |g number:5 |g day:24 |g month:09 |g pages:842-860 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/mas.21691 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2022 |e 5 |b 24 |c 09 |h 842-860 | ||